INTERNATIONAL PATENT: JUNO THERAPEUTICS, INC. FILES APPLICATION FOR "GENETICALLY ENGINEERED T CELLS EXPRESSING A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) AND USES THEREOF FOR ALLOGENEIC CELL THERAPY"

GENEVA, Nov. 19 -- JUNO THERAPEUTICS, INC. (400 Dexter Avenue NorthSuite 1200Seattle, Washington 98109) filed a patent application (PCT/US2025/028570) for "GENETICALLY ENGINEERED T CELLS EXPRESSING A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) AND USES THEREOF FOR ALLOGENEIC CELL THERAPY" on May 09, 2025. With publication no. WO/2025/235851, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHAN, Calvin (c/o Juno Therapeutics, Inc.400 Dexter Avenue NorthSuite 1200Seattle, Washington 98109), CLEYRAT, Cedric (c/o Juno Therapeutics, ...